VCEL vs. BVS
VCEL (Vericel Corporation) and BVS (Bioventus Inc.) are both stocks. Both are in the Healthcare sector — VCEL in Biotechnology, BVS in Medical Devices. Over the past 5 years, VCEL returned -9.01%/yr vs -13.88%/yr for BVS. At a 0.31 correlation, their price movements are largely independent.
Performance
VCEL vs. BVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VCEL achieves a -3.53% return, which is significantly lower than BVS's 14.92% return.
VCEL
- 1D
- 0.84%
- 1M
- -4.80%
- YTD
- -3.53%
- 6M
- -7.09%
- 1Y
- -16.43%
- 3Y*
- 1.80%
- 5Y*
- -9.01%
- 10Y*
- 29.06%
BVS
- 1D
- 5.43%
- 1M
- -15.93%
- YTD
- 14.92%
- 6M
- 12.95%
- 1Y
- 28.38%
- 3Y*
- 42.42%
- 5Y*
- -13.88%
- 10Y*
- —
VCEL vs. BVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VCEL Vericel Corporation | -3.53% | -34.42% | 54.20% | 35.19% | -32.98% | -20.17% |
BVS Bioventus Inc. | 14.92% | -29.14% | 99.24% | 101.92% | -81.99% | -24.57% |
Correlation
The correlation between VCEL and BVS is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2021 | 0.31 |
The correlation between VCEL and BVS shifts across timeframes, from 0.31 (all time) to 0.45 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
VCEL:
$1.76B
BVS:
$598.57M
VCEL:
$0.42
BVS:
$0.41
VCEL:
83.01
BVS:
20.74
VCEL:
0.57
BVS:
0.17
VCEL:
6.10
BVS:
1.02
VCEL:
4.95
BVS:
3.17
VCEL:
$292.09M
BVS:
$576.30M
VCEL:
$218.59M
BVS:
$390.14M
VCEL:
$30.07M
BVS:
$98.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VCEL vs. BVS — Risk / Return Rank
VCEL
BVS
VCEL vs. BVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vericel Corporation (VCEL) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VCEL | BVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.90 | ||
| Sortino ratioReturn per unit of downside risk | -1.37 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.15 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.46 | 1.04 | -1.50 |
| Martin ratioReturn relative to average drawdown | -0.76 | 3.80 | -4.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VCEL | BVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.34 | 0.56 | -0.90 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.17 | -0.17 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.46 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | -0.18 | +0.06 |
Drawdowns
VCEL vs. BVS - Drawdown Comparison
The maximum VCEL drawdown since its inception was -99.88%, roughly equal to the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for VCEL and BVS.
Loading charts...
Drawdown Indicators
| VCEL | BVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.88% | -95.18% | -4.70% |
Max Drawdown (1Y)Largest decline over 1 year | -35.80% | -27.51% | -8.29% |
Max Drawdown (3Y)Largest decline over 3 years | -52.52% | -55.22% | +2.70% |
Max Drawdown (5Y)Largest decline over 5 years | -73.97% | -95.07% | +21.10% |
Max Drawdown (10Y)Largest decline over 10 years | -73.97% | — | — |
Current DrawdownCurrent decline from peak | -97.54% | -55.49% | -42.05% |
Average DrawdownAverage peak-to-trough decline | -89.87% | -56.39% | -33.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.72% | 7.50% | +14.22% |
Volatility
VCEL vs. BVS - Volatility Comparison
The current volatility for Vericel Corporation (VCEL) is 11.49%, while Bioventus Inc. (BVS) has a volatility of 19.59%. This indicates that VCEL experiences smaller price fluctuations and is considered to be less risky than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VCEL | BVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.49% | 19.59% | -8.10% |
Volatility (6M)Calculated over the trailing 6-month period | 30.92% | 32.94% | -2.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.02% | 50.58% | -1.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.30% | 81.05% | -27.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.12% | 80.08% | -16.96% |
Dividends
VCEL vs. BVS - Dividend Comparison
Neither VCEL nor BVS has paid dividends to shareholders.
Financials
VCEL vs. BVS - Financials Comparison
This section allows you to compare key financial metrics between Vericel Corporation and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VCEL vs. BVS - Profitability Comparison
VCEL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vericel Corporation reported a gross profit of 49.27M and revenue of 68.43M. Therefore, the gross margin over that period was 72.0%.
BVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.
VCEL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vericel Corporation reported an operating income of -8.06M and revenue of 68.43M, resulting in an operating margin of -11.8%.
BVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.
VCEL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vericel Corporation reported a net income of -6.30M and revenue of 68.43M, resulting in a net margin of -9.2%.
BVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.
Frequently Asked Questions
VCEL and BVS have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BVS has higher volatility (19.59%) compared to VCEL (11.49%). In terms of maximum drawdown, VCEL dropped -99.88% vs BVS's -95.18%.
BVS currently has the higher Sharpe Ratio (0.56 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VCEL and BVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer